Skip to main content
. 2023 Jul 19;94:104706. doi: 10.1016/j.ebiom.2023.104706

Fig. 1.

Fig. 1

The flowchart of patients' selection. In total, 603 patients with 603 breast cancers were included as training set (489 lesions) and independent validation set (114 lesions), and 90 patients with 90 breast cancers were included as independent test set.